146 related articles for article (PubMed ID: 18598)
1. Pharmacological studies of OPC-2009, a newly synthesized selective beta adrenoceptor stimulant, in the broncho-motor and cardiovascular system of the anesthetized dog.
Yabuuchi Y; Yamashita S; Tei SS
J Pharmacol Exp Ther; 1977 Aug; 202(2):326-36. PubMed ID: 18598
[No Abstract] [Full Text] [Related]
2. Actions of procaterol (OPC-2009), a new beta2-adrenoceptor stimulant, on pulmonary resistance, contractions of the soleus muscle, and cardiovascular system of the anaesthetized cat.
Yamashita S; Takai M; Yabuuchi Y
J Pharm Pharmacol; 1978 May; 30(5):273-9. PubMed ID: 26738
[No Abstract] [Full Text] [Related]
3. Pharmacological studies of mabuterol, a new selective beta 2-stimulant. II: Effects on the cardiovascular system and smooth muscle organs.
Osada E; Murai T; Ishizaka Y; Sanai K
Arzneimittelforschung; 1984; 34(11A):1641-51. PubMed ID: 6152157
[TBL] [Abstract][Full Text] [Related]
4. [Effect of prostaglandin Bl on systemic and regional hemodynamics].
Ismailov ShI; Flerov EV
Biull Eksp Biol Med; 1977 Feb; 83(2):131-3. PubMed ID: 851612
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular and bronchomotor responses to selective beta adrenergic receptor agonists in the anesthetized dog.
Wasserman MA; Levy B
J Pharmacol Exp Ther; 1974 May; 189(2):445-55. PubMed ID: 4151394
[No Abstract] [Full Text] [Related]
6. The cardiovascular pharmacology and hemodynamic activity of tazolol, a selective myocardial beta-stimulant.
Strosberg AM
Arch Int Pharmacodyn Ther; 1976 Aug; 222(2):200-15. PubMed ID: 10864
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the selectivity of OPC-2009, a new beta2-adrenoceptor stimulatn, by the use of the blood-perfused trachea in situ and of the isolated blood-perfused papillary muscle of the dog.
Himori N; Taira N
Br J Pharmacol; 1977 Sep; 61(1):9-17. PubMed ID: 21014
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological studies with the alpha 2-adrenoceptor antagonist midaglizole. Part I: Respiratory and cardiovascular systems.
Hirohashi M; Takasuna K; Yamashita N; Tamura K
Arzneimittelforschung; 1991 Jan; 41(1):9-18. PubMed ID: 1675573
[TBL] [Abstract][Full Text] [Related]
9. [Effect of prostaglandin F2alpha on the systemic and regional hemodynamics of dogs].
Flerov EV; Ismailov ShI
Farmakol Toksikol; 1977; 40(1):44-50. PubMed ID: 852545
[TBL] [Abstract][Full Text] [Related]
10. High isoproterenol doses are required to activate beta3-adrenoceptor-mediated functions in dogs.
Pelat M; Verwaerde P; Galitzky J; Lafontan M; Berlan M; Senard JM; Montastruc JL
J Pharmacol Exp Ther; 2003 Jan; 304(1):246-53. PubMed ID: 12490598
[TBL] [Abstract][Full Text] [Related]
11. [Effects of high doses of pethidine and fentanyl on hemodynamics in the dog].
Avril G; Freye E
Cah Anesthesiol; 1984; 32(1):15-9. PubMed ID: 6529629
[No Abstract] [Full Text] [Related]
12. [Relationship between pharmacological effect and chemical structure of new pyrimidine derivatives. II. Effect on various hemodynamic and biochemical parameters].
Oledzka K
Acta Pol Pharm; 1979; 36(2):251-8. PubMed ID: 532681
[No Abstract] [Full Text] [Related]
13. Hemodynamic and coronary vasodilative properties of a selective and full beta 1-adrenoceptor agonist, T-0509, in comparison with isoproterenol in anesthesized dogs.
Yamazaki J; Sugimoto T; Yabana H; Nagao T
J Cardiovasc Pharmacol; 1994 Aug; 24(2):209-15. PubMed ID: 7526052
[TBL] [Abstract][Full Text] [Related]
14. Effects of dobutamine on coronary circulation and cardiac metabolism of the dog.
Sakanashi M; Tomomatsu E; Takeo S; Araki H; Iwasaki K; Sakamoto K; Takenaka F
Arzneimittelforschung; 1978; 28(5):798-801. PubMed ID: 581958
[TBL] [Abstract][Full Text] [Related]
15. Effects of coronary blood flow, myocardial contractility, and heart rate on cardiac lymph circulation in open-chest dogs. Use of a direct cannulation method for subepicardial lymph vessel.
Saito D; Hasui M; Shiraki T; Kono H
Arzneimittelforschung; 1997 Feb; 47(2):119-24. PubMed ID: 9079229
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological studies of a newly synthetized 1,4-dihydropyridine derivative, 2,6-dimethyl-3,5-dimethoxycarbonyl-4- (o-difluoromethoxyphenyl)-1,4-dihydropyridine (PP-1466).
Toribatake T; Fujii K; Kobayashi M; Okumura M; Aikawa K
Arzneimittelforschung; 1985; 35(4):680-6. PubMed ID: 4015734
[TBL] [Abstract][Full Text] [Related]
17. Transmural ventricular distribution of coronary blood flow during coronary beta 2-adrenergic receptor activation in dogs.
Domenech RJ; MacLellan PR
Circ Res; 1980 Jan; 46(1):29-36. PubMed ID: 6101266
[No Abstract] [Full Text] [Related]
18. [Effects of glucagon on systemic circulation, coronary blood flow and myocardial oxygen consumption in the anesthetized dog (author's transl)].
Tarnow J; Gethmann JW; Patschke D; Weymar A; Eberlein HJ
Arzneimittelforschung; 1975; 25(12):1906-10. PubMed ID: 1243661
[TBL] [Abstract][Full Text] [Related]
19. Regional blood flow and cardiac responses to hydralazine.
Spokas EG; Wang HH
J Pharmacol Exp Ther; 1980 Feb; 212(2):294-303. PubMed ID: 7351643
[No Abstract] [Full Text] [Related]
20. Some cardiac metabolic and haemodynamic alterations due to adrenergic beta-receptor blockade.
Szekeres L; Udvary E; Papp JG
Acta Biol Med Ger; 1972; 28(6):1031-9. PubMed ID: 4404698
[No Abstract] [Full Text] [Related]
[Next] [New Search]
